GSK Quick Ratio 2010-2022 | GSK

Historical quick ratio values for GSK (GSK) over the last 10 years.
GSK Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2022-12-31 $19.32B $28.21B 0.69
2022-09-30 $18.36B $24.68B 0.74
2022-06-30 $62.18B $47.50B 1.31
2022-03-31 $30.84B $32.58B 0.95
2021-12-31 $17.73B $32.55B 0.55
2021-09-30 $16.56B $30.91B 0.54
2021-06-30 $15.71B $29.90B 0.53
2021-03-31 $16.97B $27.96B 0.61
2020-12-31 $18.30B $28.44B 0.64
2020-09-30 $17.36B $28.65B 0.61
2020-06-30 $20.58B $29.69B 0.69
2020-03-31 $20.59B $32.45B 0.63
2019-12-31 $17.29B $30.71B 0.56
2019-09-30 $17.53B $31.46B 0.56
2019-06-30 $15.77B $33.14B 0.48
2019-03-31 $15.43B $31.86B 0.48
2018-12-31 $15.29B $30.02B 0.51
2018-09-30 $15.15B $23.97B 0.63
2018-06-30 $15.11B $24.77B 0.61
2018-03-31 $14.98B $37.47B 0.40
2017-12-31 $13.34B $34.24B 0.39
2017-09-30 $15.70B $35.92B 0.44
2017-06-30 $13.66B $36.81B 0.37
2017-03-31 $14.08B $23.23B 0.61
2016-12-31 $15.73B $25.75B 0.61
2016-09-30 $16.07B $23.82B 0.68
2016-06-30 $16.34B $25.98B 0.63
2016-03-31 $15.32B $19.94B 0.77
2015-12-31 $18.15B $20.52B 0.89
2015-09-30 $18.80B $19.77B 0.95
2015-06-30 $20.40B $21.13B 0.97
2015-03-31 $24.69B $23.93B 1.03
2014-12-31 $17.22B $21.91B 0.79
2014-09-30 $17.69B $25.52B 0.69
2014-06-30 $15.89B $20.62B 0.77
2014-03-31 $15.15B $19.31B 0.78
2013-12-31 $17.72B $21.40B 0.83
2013-09-30 $14.42B $19.89B 0.73
2013-06-30 $14.28B $19.17B 0.75
2013-03-31 $15.41B $18.66B 0.83
2012-12-31 $15.41B $21.90B 0.70
2012-09-30 $14.94B $22.06B 0.68
2012-06-30 $21.07B $24.39B 0.86
2012-03-31 $19.28B $22.83B 0.84
2011-12-31 $19.72B $24.08B 0.82
2011-09-30 $19.92B $21.13B 0.94
2011-06-30 $19.65B $22.23B 0.88
2011-03-31 $20.44B $20.99B 0.97
2010-12-31 $18.86B $19.51B 0.97
2010-09-30 $19.71B $17.42B 1.13
2010-06-30 $19.41B $17.91B 1.08
2010-03-31 $22.17B $18.98B 1.17
2009-12-31 $21.15B $18.98B 1.12
2009-09-30 $21.58B $18.26B 1.18
2009-06-30 $17.56B $13.99B 1.26
2009-03-31 $18.49B $14.02B 1.32
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $75.923B $36.279B
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $140.576B 8.70
Bio-Rad Laboratories (BIO.B) United States $13.735B 32.61
QIAGEN (QGEN) Netherlands $10.436B 19.34
Ginkgo Bioworks Holdings (DNA) United States $2.549B 0.00
Arcus Biosciences (RCUS) United States $1.194B 0.00
Biohaven (BHVN) United States $0.913B 0.00
Emergent Biosolutions (EBS) United States $0.394B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.152B 0.00
Enzo Biochem (ENZ) United States $0.106B 0.00
SQZ Biotechnologies (SQZ) United States $0.024B 0.00
Gelesis Holdings (GLS) United States $0.012B 0.00